News related to Revlimid (Lenalidomide) and/or conditions it is approved for
Source: MedicineNet Amyloidosis Specialty [2017.02.27]
Title: Multiple Myeloma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/27/2017 12:00:00 AM
Inhibition of EZH2 might be new therapy of multiple myeloma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2017.01.13]
In a study published in the scientific journal Oncotarget, researchers from Uppsala University show how the protein EZH2 affects the development of multiple myeloma, and that inhibition of EZH2...
Method may help myeloma patients avoid painful biopsies
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2017.04.06]
Multiple myeloma is a cancer of the plasma cells, which are white blood cells produced in bone marrow that churn out antibodies to help fight infection.
Aggressive form of leukaemia linked to defective 'protein factory'
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.12.14]
20 to 40 percent of the patients with multiple myeloma - a type of leukaemia - have a defect in the ribosome, the protein factory of the cell.